by • February 17, 2016 • No Comments
Until not long ago, 3D bioprinting was all but unheard of. Now, it’s equitewhere as research institutions and private companies alike scramble to be a part of this quickly expanding, lifesaving, ingenious industry. Most of the news coming out of the bioprinting sector comes of hospitals, universities, and research laboratories as they create new methods of 3D printing human tissue. So far, only a few companies have createed and marketed 3D printing equipment specifically created for bioprinting, so it’s always big news when a new one hits the market.
Last year, South Korean 3D printing device developer Rokit revealed that they may be entering the 3D bioprinting space next a $3 million grant of the government. At the time, the company noted that one of their ultimate goals was to create a 3D bioprinting device; now, less than a year later, it seems that they’ve may already reached that goal. Rokit has officially revealed the release of the 3Dison Invivo, a “tissue engineering and bio-medical research 3D printing device.”
The Invivo is the latest addition to the company’s line of multi-material 3Dison printing equipment, and it looks to be a highly verstatile bioprinting device, with both an extruder and a liquid dispenser. According to Rokit, the Invivo can print with a multitude of materials that include PLGA, PCL, PLLA, collagen, alginate, and silk fibroin. The company in addition states that the Invivo can do away with most of the disadvantages of existing bioprinting equipment.
“Compared to the increase in demand for 3D printing three-dimensional tissue engineering research, price of existing products is too expensive,” company officials said. “In most cases 3d bio printing equipment focus on easy mechanical efficiency rather than specifications that researchers want.”
Rokit has a rather great thought of what researchers want, as their CEO Seok Hwan You is the former CEO of Celltrion Healthcare, a biopharmaceutical research and createment company. He drew on his extensive biological knowledge gained in his previous employment and combined it with 3D printing innovation to create the Invivo, that he hopes can “contribute to pioneered new areas in Korea’s bio-industry.”
The 3Dison Invivo can officially hit the market in April; no word as to what its cost can be only yet. It won’t be the last of Rokit’s contributions to the bioprinting market; the company has noted that they intend to follow up with a 3D bioprinting device created to print patient-specific skin. 3D printing skin tissue was one of the primary focus areas at the quite beginning of the government-funded project that Rokit has been collaborating on with the Korea Institute of Machinery and Materials, Seoul National University Hospital, Korea Advanced Institute of Science and Technology, and Hanyang University. The project, for that the $3 million grant was awarded, aims to create a novel form of bioprinting that can allow for skin to be applied directly to patients, revolutionizing the treatment of burns and other skin injure. Discuss this new innovation in the Rokit 3D Bioprinting device forum over at 3DPB.com.
by admin • March 5, 2017
by admin • November 28, 2016
by admin • November 28, 2016